Delivery Order SPE2DB22D2206-SPE2DB24FGH58
Award Date
3/26/24
Potential Completion Date
3/27/24
Potential Value
$7.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $12,507.37 to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distribution company AmerisourceBergen Corporation. This order is for the supply of the specialty pharmaceutical product Dupixent 300 mg/2 ml pen, with an ultimate completion date of March 19, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm-fixed-price delivery order contract worth $4,957.05 for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,860.27 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 200 mg/1.14 ml pens. The award has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a $5,980.54 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of Dupixent 300 mg/2 ml syringes, with a period of performance through April 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $60,934.22 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml pens. This contract has an ultimate completion date of April 3, 2024. AmerisourceBergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,853.26 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the procurement of Dupixent 300 mg/2 ml pens and has an ultimate completion date of March 14, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which was issued under a larger indefinite delivery contract (IDC) valued up to $999,999,999.00 that runs through...
The U.S. Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,853.26 firm fixed price delivery order contract (SPE2DB22D3004|SPE2DB24FPV69) to provide the pharmaceutical product Dupixent 300 mg/2 ml pen. This contract has an ultimate completion date of April 3, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 and a...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order (SPE2DX15D1053|SPE2DX24F6KHK) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of the pharmaceutical product Dupixent 200 mg/1.14 ml pen. The delivery order, valued at $2,703.29, has an ultimate completion date of April 9, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on an indefinite delivery contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 300 mg/2 mL Dupixent pens valued at $35,798.43. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025, to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $32,672.79 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a completion date of August 2, 2024. Amerisourcebergen is one of the largest pharmaceutical distributors in the United States, providing a wide range of medical commodities to federal agencies and...